Minocycline after successful stroke clot removal in the back brain
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether an antibiotic called minocycline can reduce brain damage after doctors successfully remove a blood clot from the back of the brain (posterior circulation stroke) using a catheter procedure. The drug may help protect brain tissue and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Stroke symptoms started within the last 24 hours (or upon waking up)
- Moderate to severe stroke symptoms (NIHSS score of 6 or higher)
- Brain imaging shows good tissue remaining in the back of the brain (ASPECTS score of 6 or higher)
- Blood clot successfully removed from the vertebral or basilar artery in the back of the brain
- Able to give written consent or have a legal representative do so
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether minocycline, an antibiotic, can reduce brain damage when given after successful clot removal surgery for acute stroke. The goal is to see if this medication helps patients recover better.
This trial tests if a procedure to remove a blood clot from the main artery in the back of the brain (basilar artery) can help people who have a large stroke. The procedure is done within 24 hours of symptom onset, and researchers want to see if it can reduce disability.
This study tests whether adding the antibiotic levofloxacin to standard emergency clot-removal (endovascular thrombectomy) is safer and more effective for people with an acute ischemic stroke. It may help by reducing complications after the procedure, but it’s being studied to confirm benefits and risks.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial tests whether removing a blood clot from a large brain artery is better than standard medical care for people who have a mild stroke (NIHSS score 2-5) but still have symptoms like trouble speaking, weakness, or confusion. It is for patients who can be treated within 24 hours of their last known well time.
This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.